Cargando…

Bowel Location Rather Than Disease Subtype Dominates Transcriptomic Heterogeneity in Pediatric IBD

Detalles Bibliográficos
Autores principales:	Venkateswaran, Suresh, Marigorta, Urko M., Denson, Lee A., Hyams, Jeffrey S., Gibson, Greg, Kugathasan, Subra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198018/ https://www.ncbi.nlm.nih.gov/pubmed/30364773 http://dx.doi.org/10.1016/j.jcmgh.2018.07.001

Ejemplares similares

Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease
por: Mo, Angela, et al.
Publicado: (2018)

Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn’s disease
por: Pelia, Ranjit, et al.
Publicado: (2021)

Neutrophil GM-CSF signaling in inflammatory bowel disease patients is influenced by non-coding genetic variants
por: Venkateswaran, Suresh, et al.
Publicado: (2019)

A simulation study of gene-by-environment interactions in GWAS implies ample hidden effects
por: Marigorta, Urko M., et al.
Publicado: (2014)

Longitudinal DNA methylation profiling of the rectal mucosa identifies cell-specific signatures of disease status, severity and clinical outcomes in ulcerative colitis cell-specific DNA methylation signatures of UC
por: Venkateswaran, Suresh, et al.
Publicado: (2023)

Pervasive Modulation of Obesity Risk by the Environment and Genomic Background
por: Nagpal, Sini, et al.
Publicado: (2018)

Altered splicing associated with the pathology of inflammatory bowel disease
por: Berger, Kiera, et al.
Publicado: (2021)

Expression quantitative trait locus analysis for translational medicine
por: Gibson, Greg, et al.
Publicado: (2015)

Methylation quantitative trait loci are largely consistent across disease states in Crohn’s disease
por: Venkateswaran, Suresh, et al.
Publicado: (2022)

PART of the WHOLE: A Case Study in Wellness-Oriented Personalized Medicine
por: Gibson, Greg, et al.
Publicado: (2015)

Transcriptional Risk Scores link GWAS to eQTL and Predict Complications in Crohn's Disease
por: Marigorta, Urko M., et al.
Publicado: (2017)

Growth orientations, rather than heterogeneous growth rates, dominate jaw joint morphogenesis in the larval zebrafish
por: Godivier, Josepha, et al.
Publicado: (2022)

Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen
por: Soomro, Sanam, et al.
Publicado: (2021)

High Trans-ethnic Replicability of GWAS Results Implies Common Causal Variants
por: Marigorta, Urko M., et al.
Publicado: (2013)

Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD
por: Verstockt, Bram, et al.
Publicado: (2023)

Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease
por: Rodríguez-Lago, Iago, et al.
Publicado: (2023)

Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy
por: Anbazhagan, Murugadas, et al.
Publicado: (2023)

Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping
por: Cutler, David J., et al.
Publicado: (2015)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Ileal Derived Organoids From Crohn’s Disease Patients Show Unique Transcriptomic and Secretomic Signatures
por: Niklinska-Schirtz, Barbara Joanna, et al.
Publicado: (2021)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
por: Tindemans, Irma, et al.
Publicado: (2020)

The role of admixture in the rare variant contribution to inflammatory bowel disease
por: Astore, Courtney, et al.
Publicado: (2023)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Not All that Strictures Is IBD: Gastric Heterotopia Leading to Perforation and Small Bowel Obstruction Mimicking IBD
por: Ralbovsky, Amariel, et al.
Publicado: (2022)

Bimanual grasp planning reflects changing rather than fixed constraint dominance
por: van der Wel, Robrecht P. R. D., et al.
Publicado: (2010)

Visual fixations rather than saccades dominate the developmental eye movement test
por: Tanke, Nouk, et al.
Publicado: (2021)

Adaptive evolution of loci covarying with the human African Pygmy phenotype
por: Mendizabal, Isabel, et al.
Publicado: (2012)

Inflammatory bowel diseases in Faroese‐born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development
por: Hammer, T., et al.
Publicado: (2017)

Diarrhea
por: Kugathasan, Subra
Publicado: (2004)

Spatial heterogeneity lowers rather than increases host–parasite specialization
por: Hesse, E., et al.
Publicado: (2015)

Controlled drug release for inflammatory bowel disease (IBD)
por: Asha, D, et al.
Publicado: (2020)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

The gut microbiota heterogeneity and assembly changes associated with the IBD
por: Sun, Yang, et al.
Publicado: (2019)

Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme
por: Evans, Subhadra, et al.
Publicado: (2022)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mh7rfuc3hgoreomh53skmvfst8